Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Axcan Pharma US Inc history
Axcan Pharma US Inc company history timeline
Then, in June 1994 the company bought a 75 percent interest in Calgary-based Western Dialysis Supplies Ltd., maker of concentrated acid solutions for hemodialysis.
In 1995 Axcan allied itself with the Swedish firm Althin AB, creating a joint venture to manufacture concentrated solutions for hemodialysis at the Biopharm and Western Dialysis facilities, the product to be sold in Canada and distributed worldwide by Althin.
In March 1996, Axcan filed a "New Drug Application" with the FDA for URSO. In the meantime the company made advances on other fronts.
More products were added to the company's portfolio in September 1997 through acquisition.
Over the course of 1999, Axcan also gained a toehold in Europe, buying a 50 percent stake in a Polish company, Bonne Sante SP. z.o. o., which distributed gastrointestinal products in Poland.
Axcan expanded its marketing capacity in 1999.
"Axcan Pharma Inc.—Named One of Canada's Fastest Growing Technology Companies In—The 2001 Deloitte & Touche Canadian Technology Fast 50," Market News Publishing, September 21, 2001.
Also of note in 2001, Axcan acquired a Paris-based firm, Laboratoires Enteris, a marketer of gastrointestinal products.
The year 2003 was marked by a failed hostile takeover bid of Raleigh, North Carolina-based Salix Pharmaceuticals Inc.
In fiscal 2004 revenues reached $243.6 million and net income approached $50 million.
In May 2005 Gosselin stepped down as chief executive, turning over the reins to Frank Verwiel while staying on as chairman of the board.
"Axcan Pharma Inc. ." International Directory of Company Histories, Volume 85. . Retrieved June 21, 2022 from Encyclopedia.com: https://www.encyclopedia.com/reference/dictionaries-thesauruses-pictures-and-press-releases/axcan-pharma-inc
Rate Axcan Pharma US Inc's efforts to communicate its history to employees.
Axcan Pharma US Inc jobs
Do you work at Axcan Pharma US Inc?
Does Axcan Pharma US Inc communicate its history to new hires?
Axcan Pharma US Inc competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Evoke Pharma | 2007 | $1.0M | 6 | - |
| Takeda Pharmaceuticals U.S.A., Inc. | 1998 | $12.1B | 30,481 | 1,229 |
| Depomed | 1995 | $342.7M | 494 | - |
| Brad Pharm | 1985 | $145.0M | 300 | - |
| Pharmacia | 1901 | $130.0M | 350 | - |
| Santarus | 1996 | $218.0M | 290 | - |
| Hill Dermaceuticals | - | $7.5M | 46 | - |
| Xanodyne Pharmaceuticals | 2000 | $18.8M | 100 | - |
| Daiichi Sankyo | 2005 | $9.0B | 15,348 | 40 |
| Eisai | 1995 | $5.3B | 1,864 | 148 |
Axcan Pharma US Inc history FAQs
Zippia gives an in-depth look into the details of Axcan Pharma US Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Axcan Pharma US Inc. The employee data is based on information from people who have self-reported their past or current employments at Axcan Pharma US Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Axcan Pharma US Inc. The data presented on this page does not represent the view of Axcan Pharma US Inc and its employees or that of Zippia.
Axcan Pharma US Inc may also be known as or be related to APTALIS PHARMA INC, Aptalis Pharma US Inc, Axcan Pharma US and Axcan Pharma US Inc.